| Human circulating PD-1+ CXCR3− CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses M Locci, C Havenar-Daughton, E Landais, J Wu, MA Kroenke, ... Immunity 39 (4), 758-769, 2013 | 866 | 2013 |
| IL-12–and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition MA Kroenke, TJ Carlson, AV Andjelkovic, BM Segal The Journal of experimental medicine 205 (7), 1535-1541, 2008 | 709 | 2008 |
| Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation MA Kroenke, D Eto, M Locci, M Cho, T Davidson, EK Haddad, S Crotty The Journal of Immunology 188 (8), 3734-3744, 2012 | 393 | 2012 |
| The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease T Carlson, M Kroenke, P Rao, TE Lane, B Segal The Journal of experimental medicine 205 (4), 811-823, 2008 | 322 | 2008 |
| BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms K Hatzi, JP Nance, MA Kroenke, M Bothwell, EK Haddad, A Melnick, ... Journal of Experimental Medicine 212 (4), 539-553, 2015 | 272 | 2015 |
| GM-CSF–dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization IL King, MA Kroenke, BM Segal Journal of Experimental Medicine 207 (5), 953-961, 2010 | 223 | 2010 |
| EAE mediated by a non‐IFN‐γ/non‐IL‐17 pathway MA Kroenke, SW Chensue, BM Segal European journal of immunology 40 (8), 2340-2348, 2010 | 125 | 2010 |
| Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune … MA Kroenke, BM Segal Journal of neuroscience research 85 (8), 1685-1693, 2007 | 57 | 2007 |
| IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway MA Kroenke, BM Segal Brain, behavior, and immunity 25 (5), 932-937, 2011 | 50 | 2011 |
| International AIDS Vaccine Initiative Protocol C Principal Investigators Human circulating PD-1+ CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly … M Locci, C Havenar-Daughton, E Landais, J Wu, MA Kroenke, ... Immunity 39 (4), 758-769, 2013 | 37 | 2013 |
| International AVIPCPI, Poignard P, Crotty S. 2013. Human circulating PD-1+ CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV … M Locci, C Havenar-Daughton, E Landais, J Wu, MA Kroenke, ... Immunity 39 (4), 758-769, 0 | 33 | |
| Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology Y Zhou, HL Penny, MA Kroenke, B Bautista, K Hainline, LS Chea, ... Journal for Immunotherapy of Cancer 10 (4), 2022 | 26 | 2022 |
| Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays A Ducret, C Ackaert, J Bessa, C Bunce, T Hickling, V Jawa, MA Kroenke, ... MAbs 14 (1), 1993522, 2022 | 23 | 2022 |
| Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: method development challenges and anti-drug antibody clinical impact assessments MA Kroenke, DK Weeraratne, H Deng, B Sloey, R Subramanian, B Wu, ... Journal of Immunological Methods 445, 37-44, 2017 | 19 | 2017 |
| Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity F Civoli, MA Kroenke, K Reynhardt, Y Zhuang, A Kaliyaperumal, S Gupta Bioanalysis 4 (22), 2725-2735, 2012 | 18 | 2012 |
| Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response M Starcevic Manning, MA Kroenke, SA Lee, SE Harrison, SA Hoofring, ... Bioanalysis 9 (23), 1849-1858, 2017 | 14 | 2017 |
| Immunogenicity risk assessment for multi-specific therapeutics MA Kroenke, MN Milton, S Kumar, E Bame, JT White The AAPS journal 23 (6), 115, 2021 | 11 | 2021 |
| AB0432 efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory T cells in patients with SLE: final results of a phase 1b multiple ascending dose study N Tchao, N Sarkar, X Hu, R Zhang, C Milmont, YS Jin, V Chow, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1343-1344, 2022 | 8 | 2022 |
| A proposal to redefine clinical immunogenicity assessment DT Mytych, MB Hock, M Kroenke, V Jawa, A Kaliyaperumal, Y Zhou The AAPS journal 19, 599-602, 2017 | 8 | 2017 |
| Survey outcome on immunogenicity risk assessment tools for biotherapeutics: an insight into consensus on methods, application, and utility in drug development J Gokemeijer, Y Wen, V Jawa, S Mitra-Kaushik, S Chung, A Goggins, ... The AAPS Journal 25 (4), 55, 2023 | 3 | 2023 |
